1. Home
  2. BSET vs SCLXW Comparison

BSET vs SCLXW Comparison

Compare BSET & SCLXW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bassett Furniture Industries Incorporated

BSET

Bassett Furniture Industries Incorporated

HOLD

Current Price

$16.90

Market Cap

132.4M

ML Signal

HOLD

Logo Scilex Holding Company

SCLXW

Scilex Holding Company

HOLD

Current Price

$0.16

Market Cap

0.0

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BSET
SCLXW
Founded
1902
N/A
Country
United States
United States
Employees
N/A
31
Industry
Home Furnishings
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
132.4M
N/A
IPO Year
1987
N/A

Fundamental Metrics

Financial Performance
Metric
BSET
SCLXW
Price
$16.90
$0.16
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
23.8K
4.0K
Earning Date
01-28-2026
03-07-2025
Dividend Yield
4.69%
N/A
EPS Growth
N/A
N/A
EPS
0.90
N/A
Revenue
$330,953,000.00
$55,152,000.00
Revenue This Year
$3.11
N/A
Revenue Next Year
$3.00
N/A
P/E Ratio
$19.01
N/A
Revenue Growth
N/A
22.02
52 Week Low
$13.58
$0.18
52 Week High
$19.75
$0.18

Technical Indicators

Market Signals
Indicator
BSET
SCLXW
Relative Strength Index (RSI) 69.05 41.02
Support Level $15.01 $0.17
Resistance Level $16.02 $0.21
Average True Range (ATR) 0.56 0.03
MACD 0.19 -0.00
Stochastic Oscillator 93.43 30.64

Price Performance

Historical Comparison
BSET
SCLXW

About BSET Bassett Furniture Industries Incorporated

Bassett Furniture Industries Inc is a manufacturer, marketer, and retailer of home furnishings products in the United States. It operates through the following segments: The Wholesale segment focuses on the design, manufacture, sourcing, sale, and distribution of furniture products, the Retail segment which consists of company-owned stores, and the Corporate and others segment. Majority of revenue is from Wholesale sales of furniture and accessories.

About SCLXW Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.

Share on Social Networks: